Hatteras Venture Partners

Hatteras Venture Partners is a venture capital firm established in 2000. The firm was founded by Clay B. Thorp and John Crumpler. It operates from its headquarters in Durham, North Carolina. As of March 2019, the firm has 44 active companies in its portfolio and has sold off its ownership in 35 companies. It has most recently invested in Kymera on November 2018, a company specializing in the development of biotechnology to treat untreatable diseases.

Hatteras Venture Partners’ primary investment focus is in companies providing products and services in the field of biopharmaceuticals, medical devices, diagnostic, healthcare information technology and medicine sectors. The firm funds companies in various stages of development, from early stage to mid-venture. It prefers to fund companies operating from the Southeastern states of the U.S., such as North Carolina. Its latest funding round was held in January 2017, which managed to amass a total of $150 million.

Hatteras Venture Partners is a venture capital firm established in 2000. The firm was founded by Clay B. Thorp and John Crumpler. It operates from its headquarters in Durham, North Carolina. As of March 2019, the firm has 44 active companies in its portfolio and has sold off its ownership in 35 companies. It has most recently invested in Kymera on November 2018, a company specializing in the development of biotechnology to treat untreatable diseases.

Hatteras Venture Partners’ primary investment focus is in companies providing products and services in the field of biopharmaceuticals, medical devices, diagnostic, healthcare information technology and medicine sectors. The firm funds companies in various stages of development, from early stage to mid-venture. It prefers to fund companies operating from the Southeastern states of the U.S., such as North Carolina. Its latest funding round was held in January 2017, which managed to amass a total of $150 million.